Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.22%)
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Joshua J. Dapice(9.99%),Philip D. Dreyfuss(9.99%)等
Longboard Pharmaceuticals | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(8.3%)
Longboard Pharmaceuticals | 10-Q:季度报表
Longboard Pharmaceuticals | 8-K:Longboard Pharmicals公布2024年第三季度财务业绩并提供公司最新情况
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(1.401%),Abigail P. Johnson(1.401%)
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(11.182%),Abigail P. Johnson(11.182%)
Longboard Pharmaceuticals | SC TO-T/A:发行招标公告
Longboard Pharmaceuticals | SC 14D9/A:招标/推荐声明(修正)
Longboard Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.22%)
Longboard Pharmaceuticals | SC 14D9:招标/推荐声明
Longboard Pharmaceuticals | SC TO-T:要约收购声明
Longboard Pharmaceuticals | 4:持股变动声明-高管 Kaye Randall
Longboard Pharmaceuticals | 4:持股变动声明-高管 Roberts Brandi
Longboard Pharmaceuticals | 4:持股变动声明-高管 Lind Kevin Robert
Longboard Pharmaceuticals | SC TO-C:投标报价书面通信
Longboard Pharmaceuticals | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(8.3%)
Longboard Pharmaceuticals | SC TO-C:投标报价书面通信
Longboard Pharmaceuticals | 4:持股变动声明-高管 Kaye Randall
Longboard Pharmaceuticals | SC14D9C:报价书面通信
暂无数据
暂无数据